Jared Gollob
Chief Tech/Sci/R&D Officer at KYMERA THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
Jared Gollob is currently the Chief Medical Officer at Kymera Therapeutics, Inc. He previously worked as the Director-Biologic Therapy Program at Duke University from 2002 to 2007 and as the Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. from 2007 to 2018.
Dr. Gollob obtained his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-03 | 95,740 ( 0.16% ) | 3 M $ | 2024-04-29 |
Jared Gollob active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-08-31 |
Former positions of Jared Gollob
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-07-31 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 2007-08-31 |
Training of Jared Gollob
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Jared Gollob
